What To Expect at the Molecular Glue Drug Development Summit

With the rise of molecular glues, this modality is emerging rapidly as a promising class of proximity inducers with huge therapeutic potential, and novel systematic approaches for finding glues are yielding new clinical candidates. Now, the community is beelining for success, with the emergence of Triana Biomedicines, a collaborative partnership between Plexium & Amgen and Monte Rosa Therapeutics initiating IND-enabling activities, and many more promising updates - this special approach is on the cusp of something truly exciting.

The Inaugural Molecular Glue Drug Development Summit has been curated as the most comprehensive forum dedicated to navigating the world of molecular glues and sharing the excitement and learnings that could further catalyze progress in the field.